Humana Stock Jumps 12% as Medicare Star Ratings Improve
Why is Humana stock up today?
Humana (HUM) stock jumped 12% to about $433 on Friday after new Medicare star ratings showed 95% of its members in four-star plans, up from 20%, and Baird upgraded it.
Key numbers
| Members in 4-star+ plans (2027) | 95%vs 20% in 2026 |
|---|---|
| Humana share price | $432.66+11.76% on the day |
| Baird price target | $596from $390 |
| Members in 4.5-star plans | 42%6 contracts rated 4.5 stars |
| J.P. Morgan expected 4-star+ share | 60%-70%actual 95% |
| Possible 2028 bonus payments (Evercore) | $4.8Bper Reuters |
What happened
Humana (HUM) stock jumped 12% to about $433 on Friday after new Medicare star ratings showed 95% of its members in four-star plans, up from 20%, and Baird upgraded it. Star ratings are government quality scores, from one to five, for private Medicare plans, and higher scores bring bonus payments. Humana's largest plan moved back up to four stars from 3.5. Baird raised its target for the stock (price target) to $596 from $390. Gains reached about 15% earlier in the day, so reported moves vary.
Why it matters
Humana matters to seniors and investors because higher star ratings bring bigger government bonus payments to the insurer. Evercore, a research firm, estimated those bonuses could reach $4.8 billion in 2028 (per). J.P. Morgan had expected only 60% to 70% of members in top-rated plans, so the result beat forecasts. Rivals UnitedHealth and CVS are expected to have fewer members in top-rated plans.
Who this affects
- MarketmixedMedium impact
- Health insurer stocks split: Humana gains, CVS slips.
- CompanybullishHigh impact
- Humana regains bonus-payment eligibility; shareholders gain.
- CompetitorsbearishMedium impact
- UnitedHealth and CVS expected to lose top-rated members.
- IndustrymixedMedium impact
- About 71% of Medicare Advantage members sit in four-star plans.
Humana vs UnitedHealth, CVS Health
How we got here
CMS publishes 2027 Medicare Advantage star ratings in the evening; Humana's main plan returns to four stars.
Humana shares rise about 14% in premarket trading on the improved ratings.
Baird upgrades Humana to Outperform and lifts its price target to $596.
What to watch
- Humana's next earnings report and 2027 outlook; Baird sees 2028 adjusted EPS near $35.69.Q4 2026
- Whether 2028 bonus payments approach Evercore's $4.8 billion estimate, reported by Reuters.2028
Educational content only. Not investment advice.
More briefsAll briefs →
Fastly Stock Jumps 15% After Analyst Upgrade
Fastly (FSLY) trades near $29 as Oppenheimer sets a $35 target on bigger security deals and AI traffic.

Yandex Stock Falls 4.5% as Drone Strikes Hit Data Centers
Yandex (YDEX) also fell 3.4% Thursday as its Sasovo hub, home to 2 of 3 AI supercomputers, shut down.

Gold Rises 0.5% to $4,130 on Weaker Dollar
Gold (XAU/USD) bounced off a two-month low near $4,100 as 10-year Treasury yields held near 5.2%.